247 related articles for article (PubMed ID: 31445817)
21. Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.
Chiotos K; Tamma PD; Flett KB; Naumann M; Karandikar MV; Bilker WB; Zaoutis T; Han JH
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971864
[TBL] [Abstract][Full Text] [Related]
22. Carbapenem-Resistant Enterobacteriaceae: An update narrative review from Saudi Arabia.
Alotaibi F
J Infect Public Health; 2019; 12(4):465-471. PubMed ID: 31060974
[TBL] [Abstract][Full Text] [Related]
23. Treating complicated carbapenem-resistant enterobacteriaceae infections with ceftazidime/avibactam: a retrospective study with molecular strain characterisation.
Krapp F; Grant JL; Sutton SH; Ozer EA; Barr VO
Int J Antimicrob Agents; 2017 Jun; 49(6):770-773. PubMed ID: 28389354
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic options for carbapenem-resistant Enterobacteriaceae infections.
Trecarichi EM; Tumbarello M
Virulence; 2017 May; 8(4):470-484. PubMed ID: 28276996
[TBL] [Abstract][Full Text] [Related]
25. Frequency of and risk factors for carbapenem-resistant
Barber KE; Wagner JL; Larry RC; Stover KR
J Med Microbiol; 2021 Feb; 70(2):. PubMed ID: 33263511
[No Abstract] [Full Text] [Related]
26. Epidemiology and risk factors for carbapenem-resistant Enterobacteriaceae colonisation and infections: case-controlled study from an academic medical center in a southern area of China.
Fang L; Lu X; Xu H; Ma X; Chen Y; Liu Y; Hong G; Liang X
Pathog Dis; 2019 Jun; 77(4):. PubMed ID: 31281931
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology and successful containment of a carbapenem-resistant Enterobacteriaceae outbreak in a Southern Italian Transplant Institute.
Mularoni A; Martucci G; Douradinha B; Campanella O; Hazen B; Medaglia A; Arena G; Gruttadauria S; Tuzzolino F; Arcadipane A; Gioè S; Luca A; Conaldi PG; Grossi P; Gridelli B
Transpl Infect Dis; 2019 Aug; 21(4):e13119. PubMed ID: 31112353
[TBL] [Abstract][Full Text] [Related]
28. Germs of thrones - spontaneous decolonization of Carbapenem-Resistant Enterobacteriaceae (CRE) and Vancomycin-Resistant Enterococci (VRE) in Western Europe: is this myth or reality?
Davido B; Moussiegt A; Dinh A; Bouchand F; Matt M; Senard O; Deconinck L; Espinasse F; Lawrence C; Fortineau N; Saleh-Mghir A; Caballero S; Escaut L; Salomon J
Antimicrob Resist Infect Control; 2018; 7():100. PubMed ID: 30123500
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and Risk Factors of Carbapenem-resistant
Kang JS; Yi J; Ko MK; Lee SO; Lee JE; Kim KH
J Korean Med Sci; 2019 May; 34(18):e140. PubMed ID: 31074254
[TBL] [Abstract][Full Text] [Related]
30. Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae.
Thaden JT; Pogue JM; Kaye KS
Virulence; 2017 May; 8(4):403-416. PubMed ID: 27384881
[TBL] [Abstract][Full Text] [Related]
31. Carbapenem-resistant Enterobacteriaceae: A retrospective review of treatment and outcomes in a long-term acute care hospital.
Igbinosa O; Dogho P; Osadiaye N
Am J Infect Control; 2020 Jan; 48(1):7-12. PubMed ID: 31431290
[TBL] [Abstract][Full Text] [Related]
32. Adult Enterobacter meningitis: a high incidence of coinfection with other pathogens and frequent association with neurosurgical procedures.
Huang CR; Lu CH; Chang WN
Infection; 2001; 29(2):75-9. PubMed ID: 11339479
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of a new selective agar medium for detection of carbapenem-resistant Enterobacteriaceae.
Kuwahara-Arai K; Morito A; Yanagisawa I; Hishinuma T; Mya S; Zan KN; Tohya M; Tada T; Tin HH; Sekiguchi JI; Watanabe S; Kirikae T
Diagn Microbiol Infect Dis; 2019 Dec; 95(4):114882. PubMed ID: 31495528
[TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics and risk factors for neonatal bloodstream infection due to carbapenem-resistant Enterobacteriaceae: A single-centre Chinese retrospective study.
Fang P; Gao K; Yang J; Li T; Sun Q; Shan Z; Wang Y
J Glob Antimicrob Resist; 2024 Jun; 37():28-36. PubMed ID: 38412919
[TBL] [Abstract][Full Text] [Related]
35. Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.
Dickstein Y; Edelman R; Dror T; Hussein K; Bar-Lavie Y; Paul M
J Hosp Infect; 2016 Sep; 94(1):54-9. PubMed ID: 27392978
[TBL] [Abstract][Full Text] [Related]
36. Post-neurosurgical meningitis caused by KPC-producing Klebsiella pneumoniae: report of two cases.
Patrial YC; Tortorelli LP; Rodrigues ACS; Santos ICO; Volpe-Chaves CE; Capato GS; Barbosa GAR; Carvalho-Assef APD; Chang MR
Rev Inst Med Trop Sao Paulo; 2019; 61():e69. PubMed ID: 31859846
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal Analysis of Risk Factors for Clinical Outcomes of
Shi YJ; Zheng GH; Qian LY; Qsman RA; Li GG; Zhang GJ
Infect Drug Resist; 2020; 13():2161-2170. PubMed ID: 32753912
[TBL] [Abstract][Full Text] [Related]
38. Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections.
Wang Q; Zhang Y; Yao X; Xian H; Liu Y; Li H; Chen H; Wang X; Wang R; Zhao C; Cao B; Wang H
Eur J Clin Microbiol Infect Dis; 2016 Oct; 35(10):1679-89. PubMed ID: 27401905
[TBL] [Abstract][Full Text] [Related]
39. Characterisation of carbapenem-resistant Enterobacteriaceae from the southwestern Ohio, northern Kentucky and southeastern Indiana region.
Mortensen JE; DeBurger B; Powell EA; DiFranco-Fisher J; Koeth L; Weissman SJ
J Glob Antimicrob Resist; 2016 Dec; 7():141-144. PubMed ID: 27835839
[TBL] [Abstract][Full Text] [Related]
40. Fecal carriage and molecular epidemiology of carbapenem-resistant Enterobacteriaceae from outpatient children in Shanghai.
Pan F; Tian D; Wang B; Zhao W; Qin H; Zhang T; Zhang H
BMC Infect Dis; 2019 Aug; 19(1):678. PubMed ID: 31370804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
